221 related articles for article (PubMed ID: 22050410)
1. Effect of buspirone, a 5-HT1A receptor agonist, on esophageal motility in healthy volunteers.
Di Stefano M; Papathanasopoulos A; Blondeau K; Vos R; Boecxstaens V; Farré R; Rommel N; Tack J
Dis Esophagus; 2012 Jul; 25(5):470-6. PubMed ID: 22050410
[TBL] [Abstract][Full Text] [Related]
2. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.
Blonski W; Vela MF; Freeman J; Sharma N; Castell DO
J Clin Gastroenterol; 2009 Mar; 43(3):253-60. PubMed ID: 18987553
[TBL] [Abstract][Full Text] [Related]
3. The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial.
Karamanolis GP; Panopoulos S; Denaxas K; Karlaftis A; Zorbala A; Kamberoglou D; Ladas SD; Sfikakis PP
Arthritis Res Ther; 2016 Sep; 18(1):195. PubMed ID: 27586891
[TBL] [Abstract][Full Text] [Related]
4. The effect of erythromycin on human esophageal motility is mediated by serotonin receptors.
Koutsoumbi P; Epanomeritakis E; Tsiaoussis J; Athanasakis H; Chrysos E; Zoras O; Vassilakis JS; Xynos E
Am J Gastroenterol; 2000 Dec; 95(12):3388-92. PubMed ID: 11151866
[TBL] [Abstract][Full Text] [Related]
5. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study.
Karamanolis GP; Panopoulos S; Karlaftis A; Denaxas K; Kamberoglou D; Sfikakis PP; Ladas SD
United European Gastroenterol J; 2015 Jun; 3(3):266-71. PubMed ID: 26137301
[TBL] [Abstract][Full Text] [Related]
7. The effect of intravenous erythromycin on esophageal motility in healthy subjects.
Tzovaras G; Xynos E; Chrysos E; Mantides A; Vassilakis JS
Am J Surg; 1996 Mar; 171(3):316-9. PubMed ID: 8615464
[TBL] [Abstract][Full Text] [Related]
8. Effect of atilmotin, a motilin receptor agonist, on esophageal, lower esophageal sphincter, and gastric pressures.
Korimilli A; Parkman HP
Dig Dis Sci; 2010 Feb; 55(2):300-6. PubMed ID: 19997977
[TBL] [Abstract][Full Text] [Related]
9. Esophageal Infusion of Menthol Does Not Affect Esophageal Motility in Patients with Gastroesophageal Reflux Disease.
Bánovčin P; Lipták P; Vážanová D; Hoferica J; Tatár M; Ďuriček M
Dysphagia; 2024 Jun; 39(3):369-375. PubMed ID: 37728794
[TBL] [Abstract][Full Text] [Related]
10. Influence of the catheter diameter on the investigation of the esophageal motility through solid-state high-resolution manometry.
Xiang X; Tu L; Zhang X; Xie X; Hou X
Dis Esophagus; 2013; 26(7):661-7. PubMed ID: 23384164
[TBL] [Abstract][Full Text] [Related]
11. Changes in esophageal and lower esophageal sphincter motility with healthy aging.
Besanko LK; Burgstad CM; Cock C; Heddle R; Fraser A; Fraser RJ
J Gastrointestin Liver Dis; 2014 Sep; 23(3):243-8. PubMed ID: 25267950
[TBL] [Abstract][Full Text] [Related]
12. Endogenous nitric oxide in the control of esophageal motility in humans.
Konturek JW; Thor P; Lukaszyk A; Gabryelewicz A; Konturek SJ; Domschke W
J Physiol Pharmacol; 1997 Jun; 48(2):201-9. PubMed ID: 9223025
[TBL] [Abstract][Full Text] [Related]
13. Buspirone, a new drug for the management of patients with ineffective esophageal motility?
Scheerens C; Tack J; Rommel N
United European Gastroenterol J; 2015 Jun; 3(3):261-5. PubMed ID: 26137300
[TBL] [Abstract][Full Text] [Related]
14. The effect of water bolus temperature on esophageal motor function as measured by high-resolution manometry.
Choi YJ; Park MI; Park SJ; Moon W; Kim SE; Kwon HJ; Kim JH; Jeon WS
Neurogastroenterol Motil; 2014 Nov; 26(11):1628-34. PubMed ID: 25307526
[TBL] [Abstract][Full Text] [Related]
15. The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers.
Cho YK; Choi MG; Han HW; Park JM; Oh JH; Jeong JJ; Cho YS; Lee IS; Kim SW; Choi KY; Chung IS
J Clin Gastroenterol; 2006 Apr; 40(4):286-92. PubMed ID: 16633098
[TBL] [Abstract][Full Text] [Related]
16. Bethanechol improves smooth muscle function in patients with severe ineffective esophageal motility.
Agrawal A; Hila A; Tutuian R; Mainie I; Castell DO
J Clin Gastroenterol; 2007 Apr; 41(4):366-70. PubMed ID: 17413603
[TBL] [Abstract][Full Text] [Related]
17. Esophageal solid bolus transit: studies using combined multichannel intraluminal impedance and manometry in healthy volunteers.
Chen CL; Yi CH; Chou AS; Liu TT
Dis Esophagus; 2013 Jan; 26(1):91-6. PubMed ID: 22394249
[TBL] [Abstract][Full Text] [Related]
18. The effect of sildenafil on lower esophageal sphincter and body motility in normal male adults.
Rhee PL; Hyun JG; Lee JH; Kim YH; Son HJ; Kim JJ; Paik SW; Rhee JC; Choi KW
Am J Gastroenterol; 2001 Dec; 96(12):3251-7. PubMed ID: 11774933
[TBL] [Abstract][Full Text] [Related]
19. Effects of GABA-B agonist baclofen on esophageal motility: Studies using high-resolution manometry.
Hung JS; Yi CH; Liu TT; Lei WY; Wong MW; Chen CL
Neurogastroenterol Motil; 2019 Dec; 31(12):e13716. PubMed ID: 31565828
[TBL] [Abstract][Full Text] [Related]
20. Double blind placebo controlled study on the effect of the nitric oxide donor molsidomin and the 5-HT3 antagonist ondansetron on human esophageal motility.
Willis S; Allescher HD; Stoschus B; Schusdziarra V; Classen M; Schumpelick V
Z Gastroenterol; 1994 Nov; 32(11):632-6. PubMed ID: 7886971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
